IL10 and peritonitis: Similarly, in mammals, during zymosan-induced peritonitis, E2 treatment promoted an anti-inflammatory and pro-resolving phenotype in zymosan-induced peritoneal macrophages, which correlated with the induction of genes involved in macrophage alternative activation and with IL-10 expression in vivo.